New hope in C. diff battle

An experimental compound has been shown to effectively fight Clostridium difficile in lab mice.

The compound mimics a natural cellular defense mechanism that neutralizes the toxins that cause C. difficile. In laboratory studies, mice treated with the compound became less ill and were more likely to survive C. diff infection than untreated mice.

“This may prove to be an alternative to antibiotics,” study author Tor Savidge, M.D., told Reuters. He added that more study is needed.

Full findings were published in the journal Nature Medicine.
close

Next Article in News

More in News

Government initiatives aim to decrease number of disabled people in nursing homes

Government initiatives aim to decrease number of disabled ...

The federal government is ramping up efforts to reduce the number of disabled people in nursing homes through interagency initiatives. While many disabled people have already been moved out of ...

Nursing home optometrist faces False Claims suit alleging excessive, unreasonable eye exams ...

An optometrist in Kentucky defrauded Medicare and Medicaid by filing claims for nursing home care that was unnecessary or not provided, alleges a False Claims Act lawsuit recently brought by the federal government.

Fecal transplants to treat C. diff now need FDA approval

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.